Chemomab Therapeutics Ltd. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€11.97K -99.9% N/A -€13.27M -34.5% N/A
    €0.00 +NaN% -€20.79M -12.4% N/A -€20.27M +16.3% N/A
    €0.00 +NaN% -€23.73M +121.6% N/A -€17.43M +67.3% N/A
    €0.00 +NaN% -€10.71M +109.7% N/A -€10.42M +133.2% N/A
    €0.00 +NaN% -€5.11M -78.1% N/A -€4.47M -68.3% N/A
    €0.00 +NaN% -€23.36M +97.2% N/A -€14.09M +17.2% N/A
    €0.00 +NaN% -€11.84M +40.7% N/A -€12.03M +65.2% N/A
    €0.00 +NaN% -€8.42M +107.2% N/A -€7.28M +132.5% N/A
    €0.00 +NaN% -€4.06M -36.9% N/A -€3.13M -50.0% N/A
    €0.00 -€6.44M N/A -€6.26M N/A

    Notifications